Physician profile
Amandeep Bhalla
NPI 1972814069
$1,836,530.51
in general payments reported to CMS, 2019-2025
37 companies · $5,372 in 2025
The $5,372 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $57K · 2021: $44K · 2022: $1.5M · 2023: $141K · 2024: $41K · 2025: $5,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $108K · Consulting Fee: $67K · Travel and Lodging: $6,947 · Food and Beverage: $5,701 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $107,696.81 |
| Consulting Fee | $66,522.20 |
| Travel and Lodging | $6,947.16 |
| Food and Beverage | $5,700.61 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $1,513,750.08 | 2020-2024 | Fibulink, Velys |
| Medical Device Business Services, INC. | $155,182.24 | 2019-2024 | Expedium, Spine & Trauma 3d Navigation, Conduit |
| Globus Medical, INC. | $71,660.28 | 2019-2025 | Creo Mis Stabilization System, Hedron Ia, Excelsius3d Imaging System |
| Orthofix Medical, INC. | $37,528.11 | 2021-2025 | Mariner Mis Tlif Retractor, Regatta Lateral System, Miscellaneous |
| Seaspine Orthopedics Corporation | $31,090.17 | 2019-2022 | |
| Depuy Synthes Sales INC. | $8,346.14 | 2019-2024 | |
| Nuvasive, INC. | $3,948.38 | 2019-2022 | |
| Alphatec Spine, INC | $3,257.13 | 2020-2024 | Other - Miscellaneous, Identiti, Biologics |
| Kyocera Medical Technologies, INC. | $2,000.00 | 2024-2025 | |
| Medtronic, INC. | $1,927.77 | 2021-2023 | Cd Horizon Spinal System, Catalyft Pl Expandable Interbody System, Stealthstation S8 Platform |
| Cerapedics INC. | $1,920.24 | 2019-2023 | I-Factor Peptide Enhanced Bone Graft |
| Zimmer Biomet Holdings, INC. | $1,899.99 | 2019-2022 | |
| Medtronic USA, INC. | $816.53 | 2019 | |
| Baxter Healthcare | $698.48 | 2019-2025 | Floseal |
| Zimvie INC. | $434.00 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $395.71 | 2019-2024 | Spinejack, Niagara Lateral Access System, Mako |
| Medicrea USA, Corp. | $250.00 | 2019 | |
| Centinel Spine, LLC | $181.00 | 2024 | Prodisc L |
| Horizon Therapeutics Plc | $173.84 | 2019 | |
| Si-Bone, INC. | $134.71 | 2022-2025 | |
| Bioventus LLC | $116.05 | 2022-2024 | Bonescalpel & Sonicone (O.R.), Bonescalpel |
| Biocomposites INC | $107.50 | 2019 | |
| Prosidyan, INC | $96.00 | 2021 | |
| Overture Orthopaedics | $83.53 | 2025 | Overtureti |
| Ethicon US, LLC | $80.34 | 2020 | |
| Innovasis INC | $59.26 | 2023 | |
| Pfizer INC. | $51.80 | 2020-2023 | |
| Abbott Laboratories | $51.31 | 2024-2025 | Eterna |
| Pacira Pharmaceuticals Incorporated | $49.09 | 2021-2022 | |
| Boston Scientific Corporation | $43.90 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Augmedics INC. | $41.46 | 2022 | |
| Providence Medical Technology, INC. | $35.87 | 2021 | |
| Nevro Corp. | $34.68 | 2022 | |
| Ossdsign USA Incorporated | $30.72 | 2025 | Ossdsign Catalyst |
| Neo Spine USA, INC. | $22.46 | 2020 | |
| Merck Sharp & Dohme LLC | $18.77 | 2023 | Bridion |
| Ermi LLC | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,695,714.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amandeep Bhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.